Genfit S.A. (GNFTF)
USD 5.55
(0.0%)
USD 5.55
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 70.17 Million EUR | -12.87% |
| 2022 | 80.54 Million USD | -4.52% |
| 2021 | 84.36 Million USD | -62.87% |
| 2020 | 227.19 Million USD | 10.23% |
| 2019 | 206.11 Million USD | 6.32% |
| 2018 | 193.86 Million USD | -1.96% |
| 2017 | 197.74 Million USD | 2902.08% |
| 2016 | 6.58 Million USD | 6.38% |
| 2015 | 6.19 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 67.81 Million USD | 0.0% |
| 2023 Q2 | 82.25 Million USD | 1.9% |
| 2023 Q3 | 73.05 Million USD | -11.19% |
| 2023 Q4 | 70.17 Million EUR | -3.94% |
| 2023 Q1 | 80.72 Million USD | 0.22% |
| 2023 FY | 70.17 Million EUR | -12.87% |
| 2022 Q2 | 78.29 Million USD | 0.0% |
| 2022 FY | 80.54 Million USD | -4.52% |
| 2022 Q3 | 72.75 Million USD | -7.08% |
| 2022 Q4 | 80.54 Million USD | 10.72% |
| 2021 Q2 | 84.11 Million USD | 0.0% |
| 2021 FY | 84.36 Million USD | -62.87% |
| 2021 Q4 | 84.36 Million USD | 0.0% |
| 2020 Q2 | 207.37 Million USD | 0.0% |
| 2020 FY | 227.19 Million USD | 10.23% |
| 2020 Q4 | 227.2 Million USD | 0.0% |
| 2019 Q4 | 206.11 Million USD | 0.0% |
| 2019 FY | 206.11 Million USD | 6.32% |
| 2019 Q2 | 207.29 Million USD | 0.0% |
| 2018 FY | 193.86 Million USD | -1.96% |
| 2017 FY | 197.74 Million USD | 2902.08% |
| 2016 FY | 6.58 Million USD | 6.38% |
| 2015 FY | 6.19 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -70.325% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -1602.565% |
| SQZ Biotechnologies Company | 27.47 Million USD | -155.466% |
| Evofem Biosciences, Inc. | 43.37 Million USD | -61.803% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -135.76% |
| Mesoblast Limited | 118.7 Million USD | 40.877% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -7300.732% |
| Genus plc | 233.1 Million USD | 69.893% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -2294.871% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -5123.269% |
| Marizyme, Inc. | 18.71 Million USD | -274.938% |
| ContraFect Corporation | 2.88 Million USD | -2335.925% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -9257.2% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -51697.589% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -4752.249% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -2917.212% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -1140.273% |
| MultiCell Technologies, Inc. | 202.58 USD | -34642510.327% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | -22.074% |
| EV Biologics, Inc. | 1.49 Million USD | -4595.029% |
| Q BioMed Inc. | 4.1 Million USD | -1607.526% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -112.015% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -11038.162% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -5613.223% |
| Biomind Labs Inc. | 735.54 Thousand USD | -9441.127% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | 59.09% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -439.963% |
| Skye Bioscience, Inc. | 4.61 Million USD | -1420.584% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -7802.471% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -49490.158% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -1095.332% |
| IMV Inc. | 28.88 Million USD | -142.969% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -272768.307% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -3007.492% |
| GB Sciences, Inc. | 1.75 Million USD | -3889.014% |
| Alpha Cognition Inc. | 1.22 Million USD | -5650.624% |
| HST Global, Inc. | 98.31 Thousand USD | -71278.879% |
| CSL Limited | 12.18 Billion USD | 99.424% |
| Halberd Corporation | 150 Thousand USD | -46686.0% |
| Enzolytics Inc. | 996.33 Thousand USD | -6943.694% |
| Resverlogix Corp. | 6.49 Million USD | -981.174% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 477.5 Thousand USD | -14597.173% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -27357.432% |
| argenx SE | 20 Million USD | -250.895% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | -54.036% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -2490.871% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -686247.188% |
| Genscript Biotech Corporation | 417.73 Million USD | 83.2% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -34881.756% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -2826.901% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -30506.958% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | -3.749% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -2219.054% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -19409.883% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -245.233% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -47109.628% |
| BioStem Technologies, Inc. | 4.71 Million USD | -1389.552% |
| ONE Bio Corp. | 19.71 Million USD | -255.967% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -27951.179% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -28116.066% |
| Agentix Corp. | 50 Thousand USD | -140258.0% |
| LadRx Corporation | 33.6 Thousand USD | -208728.781% |
| Cell Source, Inc. | 9.25 Million USD | -658.35% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -9180.432% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -9180.432% |
| NovAccess Global Inc. | 2.19 Million USD | -3090.129% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -892.236% |
| Itoco Inc. | 228.37 Thousand USD | -30629.452% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -33164.131% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -1308.368% |
| Kadimastem Ltd | 891.22 Thousand USD | -7774.434% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -17364.023% |
| CytoDyn Inc. | 30.07 Million USD | -133.339% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -14391.29% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -19845.886% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -797.434% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -57188.98% |
| Rebus Holdings, Inc. | 310 Thousand USD | -22538.387% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -1382.045% |
| International Stem Cell Corporation | 4.17 Million USD | -1579.727% |
| Bioxytran, Inc. | 1.92 Million USD | -3545.662% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -112342.921% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -3117.892% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -743.903% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -717.461% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -4411.729% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -26086.194% |
| Neutra Corp. | 54.15 Thousand USD | -129486.749% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -3734.918% |
| PureTech Health plc | 25.51 Million USD | -175.082% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -5632.52% |
| IXICO plc | 472.02 Thousand USD | -14767.708% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -352.739% |
| Gelesis Holdings, Inc. | 62.26 Million USD | -12.714% |
| CSL Limited | 12.18 Billion USD | 99.424% |
| Cellectis S.A. | 92.77 Million USD | 24.357% |